Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: vegetarian who wrote (8393)	3/5/1998 4:32:00 PM
From: AgAuUSA	Read Replies (2) \| Respond to of 14328

<<The strange thing is that when there was a huge speculation about company's earnings potential, the stock was significantly up but when the company is actually showing earnings growth (possibly not meeting high expectation), the buyers are not interested, may be that is good in a way for the long term.>> Y, agree. Seems stock price does not directly correlate to earnings. Possibly to much expectation? Possibly to many ST investors? Re share pricing: Subtract 0.75 for SLF shares from Triby stock price = 1.15. Subtract est book value of 0.80. Means we only paying 0.35 premium to actual assets. Sounds like a sound investment value to me. Maybe even a bargain for a high growth co. In any case, I doubt we going to stay here long. Most cos trade at 2-10x actual book value (I est 1.55 for Triby). By this measure we should be at a stock value of at least 3.10. Think this co is looking terribly oversold. Possibly due to poor PR? Possibly due to lack of shareholder confidence due to the poor PR? Re earns, sounds like the trend continues upward. The trend in earns is your friend. Other thoughts?